
Tonghua
600867.SSTonghua Dongbao Pharmaceutical Co., Ltd. Price (600867.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
1,979,381,895
(0.4385)%Description
Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products for the treatment of diabetes and cardiovascular-based diseases in China. The company operates through Pharmaceutical Industry and Building Materials Industry segments. Its lead product portfolio includes insulin analogues, such as insulin glargine, Insulin aspart, and insulin lispro; antidiabetic drugs; and oral hypoglycemic drugs, as well as Gan Shulin pens, blood glucose meters, and other medical devices. It offers building materials. The... Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $7.02-11.09
- Market Cap 14.72B
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Drug Manufacturers - General
- ceo: Mr. Chun Sheng Leng
- IPO Date: August, 24, 1994
- Country: CN
- Currency: CNY
- Headquaters: No Data
- Employees: 3196
- Revenue from each product or segment:
Product or Segment | Value: | % - Total | Last 3Y: |
---|

- Revenue by Region
Product or Segment | Value: | % - Total | Last 3Y: |
---|
